Results
|
|
1721.
|
|
|
|
1722.
|
|
|
|
1723.
|
|
|
|
1724.
|
|
|
|
1725.
|
Antagonistic human FcγRIIB (CD32B) antibodies have anti-tumor activity and overcome resistance to antibody therapy in vivo. [electronic resource] by
- Roghanian, Ali
- Teige, Ingrid
- Mårtensson, Linda
- Cox, Kerry L
- Kovacek, Mathilda
- Ljungars, Anne
- Mattson, Jenny
- Sundberg, Annika
- Vaughan, Andrew T
- Shah, Vallari
- Smyth, Neil R
- Sheth, Bhavwanti
- Chan, H T Claude
- Li, Zhan-Chun
- Williams, Emily L
- Manfredi, Giusi
- Oldham, Robert J
- Mockridge, C Ian
- James, Sonya A
- Dahal, Lekh N
- Hussain, Khiyam
- Nilsson, Björn
- Verbeek, J Sjef
- Juliusson, Gunnar
- Hansson, Markus
- Jerkeman, Mats
- Johnson, Peter W M
- Davies, Andrew
- Beers, Stephen A
- Glennie, Martin J
- Frendéus, Björn
- Cragg, Mark S
Producer: 20150623
In:
Cancer cell vol. 27
Availability: No items available.
|
|
|
1726.
|
|
|
|
1727.
|
|
|
|
1728.
|
|
|
|
1729.
|
|
|
|
1730.
|
|
|
|
1731.
|
|
|
|
1732.
|
|
|
|
1733.
|
|
|
|
1734.
|
|
|
|
1735.
|
|
|
|
1736.
|
|
|
|
1737.
|
|
|
|
1738.
|
|
|
|
1739.
|
|
|
|
1740.
|
|